Low serum LDL cholesterol levels are associated with elevated mortality from liver cancer in Japan: The ibaraki prefectural health study

Tohoku Journal of Experimental Medicine

Volumn 229, Issue 3, 2013, Pages 203-211

  Saito, Nobue ^a,b   Sairenchi, Toshimi ^a,b   Irie, Fujiko ^c   Iso, Hiroyasu ^d   Iimura, Kyoko ^b   Watanabe, Hiroshi ^b   Muto, Takashi ^a   Ota, Hitoshi ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Ibaraki Health Service Association   (Japan)

^c Ibaraki Prefectural Office   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholesterol; Cohort study; Liver cancer mortality; Low density lipoprotein cholesterol; Total cholesterol

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; JAPAN; LIPID ANALYSIS; LIVER CANCER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SMOKING; SURVIVAL RATE;

ADULT; AGE FACTORS; AGED; CHOLESTEROL, LDL; FASTING; FEMALE; HEALTH; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 84876307180     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.229.203     Document Type: Article

References (24)

1. Ando, E., Kuromatsu, R., Tanaka, M., Takada, A., Fukushima, N., Sumie, S., Nagaoka, S., Akiyoshi, J., Inoue, K., Torimura, T., Kumashiro, R., Ueno, T. & Sata, M. (2006) Surveillance program for early detection of hepatocellular carcinoma in Japan - Results of specialized department of liver disease. J. Clin. Gastroenterol., 40, 942-948.
2. Benn, M., Tybjaerg-Hansen, A., Stender, S., Frikke-Schmidt, R. & Nordestgaard, B.G. (2011) Low-density lipoprotein cholesterol and the risk of cancer: a Mendelian randomization study. J. Natl. Cancer Inst., 103, 508-519.
3. Cowan, L.D., Oconnell, D.L., Criqui, M.H., Barrettconnor, E., Bush, T.L. & Wallace, R.B. (1990) Cancer mortality and lipid and lipoprotein levels - the lipid research clinics program mortality follow-up-study. Am. J. Epidemiol., 131, 468-482.
4. Forns, X., Ampurdanes, S., Llovet, J.M., Aponte, J., Quinto, L., Martinez-Bauer, E., Bruguera, M., Sanchez-Tapias, J.M. & Rodes, J. (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology, 36, 986-992.
5. Friedewald, W., Levy, R.I. & Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18, 499-502.
6. Grundy, S.M., Cleeman, J.I., Merz, C.N.B., Brewer, H.B., Clark, L.T., Hunninghake, D.B., Pasternak, R.C., Smith, S.C., Stone, N.J. & Coordinating Committee of the National Cholesterol Education Program. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 110, 227-239.
7. Hasuo, Y., Ueda, K., Kiyohara, Y., Wada, J., Kawano, H., Kato, I., Yanai, T., Fujii, I., Omae, T. & Fujishima, M. (1989) Accuracy of diagnosis on death certificates for underlying causes of death in a long-term autopsy-based population study in Hisayama, Japan - with special reference to cardiovasculardiseases. J. Clin. Epidemiol., 42, 577-584.
8. Hiatt, R.A. & Fireman, B.H. (1986) Serum-cholesterol and the incidence of cancer in a large cohort. J. Chronic Dis., 39, 861-870.
9. Iso, H., Ikeda, A., Inoue, M., Sato, S., Tsugane, S. & JPHC Study Group. (2009) Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. Int. J. Cancer, 125, 2679-2686.
10. Japan Health Promotion & Fitness Foundation, Japan. (2000) Health Japan 21. Available at: http://www.kenkounippon21.gr.jp/kenkounippon21/about/kakuron/index.html [Accessed: December 29, 2012] (In Japanese).
11. Kark, J.D., Smith, A.H. & Hames, C.G. (1980) The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J. Chronic Dis., 33, 311-332.
12. Lee, E.H., Han, M.A., Lee, H.Y., Jun, J.K., Choi, K.S. & Park, E.C. (2010) Liver cancer screening in Korea: a report on the 2008 National Cancer Screening Programme. Asian Pac. J. Cancer Prev., 11, 1305-1310.
13. Levy, R.I. (1982) Cholesterol and disease - what are the facts? JAMA, 248, 2888-2890. Nago, N., Ishikawa, S., Goto, T. & Kayaba, K. (2011) Low cholesterol is associated with mortality from stroke, heart disease, and cancer: The Jichi Medical School cohort study. J. Epidemiol., 21, 67-74.
14. Nakamura, M., Sato, S. & Shimamoto, T. (2003) Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J. Atheroscler. Thromb., 10, 145-153.
15. Okamura, T., Kadowaki, T., Hayakawa, T., Kita, Y., Okayama, A., Ueshima, H. & Nippon Data80 Research Group. (2003) What cause of mortality can we predict by cholesterol screening in the Japanese general population? J. Intern. Med., 253, 169-180.
16. Okamura, T., Tanaka, H., Miyamatsu, N., Hayakawa, T., Kadowaki, T., Kita, Y., Nakamura, Y., Okayama, A. & Ueshima, H. (2007) The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis, 190, 216-223.
17. Ooi, K., Shiraki, K., Sakurai, Y., Morishita, Y. & Nobori, T. (2005) Clinical significance of abnormal lipoprotein patterns in liver diseases. Int. J. Mol. Med., 15, 655-660.
18. Rockhill, B., Newman, B. & Weinberg, C. (1998) Use and misuse of population attributable fractions. Am. J. Public Health, 88, 15-19.
19. Rose, G., Blackburn, H., Keys, A., Taylor, HL., Kannel, W.B., Paul, O., Reid, D.D. & Stamler, J. (1974) Colon cancer and blood cholesterol. Lancet, 1, 181-183.
20. Tanaka, H., Tsukuma, H., Yamano, H., Oshima, A. & Shibata, H. (2004) Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus. Int. J. Cancer, 112, 1075-1080.
21. Teramoto, T., Sasaki, J., Ueshima, H., Egusa, G., Kinoshita, M., Shimamoto, K., Daida, H., Biro, S., Hirobe, K., Funahashi, T., Yokote, K. & Yokode, M. (2007) Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J. Atheroscler. Thromb., 14, 45-50.
22. Wald, N.J., Thompson, S.G., Law, M.R., Densem, J.W. & Bailey, A. (1989) Serum-cholesterol and subsequent risk of cancer results from the BUPA study. Br. J. Cancer, 59, 936-938.
23. Weinehall, L., Johnson, O., Jansson, J.H., Boman, K., Huhtasaari, F., Hallmans, G., Dahlen, G.H. & Wall, S. (1998) Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident casecontrol study from northern Sweden. J. Intern. Med., 243, 99-107.
24. Williams, R.R., Sorlie, P.D., Feinleib, M., McNamara, P.M., Kannel, W.B. & Dawber, T.R. (1981) Cancer incidence by levels of cholesterol. JAMA, 245, 247-252.